Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Bissette, Gartha; * | Cook, Larrya | Smith, Waynea | Dole, Kenneth C.a | Crain, Barbarab | Nemeroff, Charles B.a
Affiliations: [a] Department of Psychiatry, Duke University Medical Center, Durham, NC, USA | [b] Department of Pathology, Duke University Medical Center, Durham, NC, USA
Correspondence: [*] Corresponding author: 131 Guyton Building, University of Mississippi Medical Center, 2500 North State St., Jackson, Mississippi 39216-4505, USA. Tel.: +1 601 984-6675/ 5898; Fax:.+1 601 984-5899; E-mail: [email protected]
Abstract: Background:the neuropeptides most consistently reported to be altered in Alzheimer’s disease are corticotropin-releasing factor and somatostatin (somatotropin-release inhibiting factor), although this has been previously assessed in a limited number of brain regions. Methods:in order to comprehensively characterize the involvement of these two anatomically distinct neuropeptide systems in Alzheimer’s disease and to determine if they are equally involved in the associated pathology, we measured the concentration of corticotropin-releasing factor and somatostatin in post-mortem brain tissue. Radioimmunoassay of 24 cortical and 13 sub-cortical brain regions from 16 cases of neuropathologically confirmed AD and 9 non-Alzheimer’s disease controls were performed and significant differences in group regional neuropeptide concentrations were sought using the Student Newman-Keuls test after ANOVA. Results:comparison of group mean regional neuropeptide concentrations revealed several brain regions where both peptides were decreased in Alzheimer’s disease and some regions where only one of the two peptides were decreased, while still other regions exhibited no changes in either peptide. These changes were principally found in frontal and temporal cortex, with few subcortical regions exhibiting pathologic changes in peptide concentration. Regional peptide content was correlated among peptides and with duration of dementia in several brain regions. Conclusions:these data support the hypothesis that the somatostatin- and corticotropin-releasing factor containing neurons are pathologically involved in AD and that the involved neurons are limited to specific areas of the brain.
Journal: Journal of Alzheimer's Disease, vol. 1, no. 2, pp. 91-105, 1998
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
Tel: +1 703 830 6300
Fax: +1 703 830 2300
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]spress.nl
Nieuwe Hemweg 6B
1013 BG Amsterdam
Tel: +31 20 688 3355
Fax: +31 20 687 0091
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
Free service line: 400 661 8717
Fax: +86 10 8446 7947
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]